
AFT study in @JCOOA_ASCO shows simple weekly digital symptom check-in improves quality of life and reduces emergency room visits for patients with advanced cancer by bridging communication gaps. News release - bit.ly/AFT-39. Study: bit.ly/AFT39-JCO

We are MMCORC, a #NCORP of 22 community hospitals and oncology clinics with over 250 providers offering #ClinicalTrials to people in their own communities.

AFT study in @JCOOA_ASCO shows simple weekly digital symptom check-in improves quality of life and reduces emergency room visits for patients with advanced cancer by bridging communication gaps. News release - bit.ly/AFT-39. Study: bit.ly/AFT39-JCO


“Why I Said No”: Trial-Eligible Patient Perspectives on Declining Breast Cancer Clinical Trial Participation | JCO Oncology Practice ascopubs.org/doi/10.1200/OP-…

Enroll to #StomachCancer studies @MMCORC locations - learn more below >>>
November is Gastric Cancer Awareness Month. The Alliance has two active trials aimed at improving treatments in this population – PAGODA A232402CD and A022102. Learn more about these trials at bit.ly/PAGODA26 and bit.ly/A022102.

You can search all the locally available trials @MMCORC by going to mmcorc.org/clinical-trials/ #MensHealthMatters
This @Movember the Alliance org is highlighting 8 ongoing clinical trials focused on advancing detection, treatment, and survivorship for men’s cancers, including prostate cancer. Learn more about how clinical research is shaping care: bit.ly/Movember26 #PCSM #movember

Learn about two pathways for genetic testing: myGenetics and clinical genetic testing @_HealthPartners - Also opportunities to participate in existing studies about hereditary cancer syndromes @MMCORC Meeting Registration - Meeting Registration - us06web.zoom.us/meeting/regi…

New lung cancer trial open @MMCORC 🧪A082402 is studying if targeted post op radiation (I² PORT) can reduce recurrence in high risk #NSCLC patients after surgery while limiting side effects. Learn more bit.ly/I-PORT-Trial. #LungCancer #ClinicalTrials #RadiationTherapy

Patients with newly diagnosed #MultipleMyeloma may be eligible to participate in #ClinicalTrial at mmcorc.org/locations EAA181/EQUATE. Learn more here: bit.ly/eaa181equate


ICYMI – the October issue of the NRG Oncology newsletter is available. This issue highlights plenty of content for #BreastCancerAwarenessMonth. Check it out here: ow.ly/Cvce50ZXl9o

@MMCORC at AICAF Powwow for Hope along with our consortium members @HennepinHC @AllinaHealth and @mnoncology. It was a community healing event that celebrated Native cancer survivors and strengthened connections towards eliminating the cancer burdens of Indigenous people.

Sharing with you @NRGonc communication that takes community members behind the scenes of research process and results > including SUMMARY OF RESULTS FOR PATIENTS section.
NRG Oncology Weekly Broadcast for October 19, 2026: conta.cc/4A26umD

NRG Oncology is currently accepting applications for travel awards to #NRG2027 in Las Vegas! Application window closes November 9th. More information can be found at ow.ly/oJEj50ZZ617

792 locations, including @MMCORC! A022102 is studying mFOLFIRINOX vs mFOLFOX with or without immunotherapy drug nivolumab for metastatic HER2 negative esophageal, gastroesophageal junction and gastric cancer. More: bit.ly/Alliance-A022102 #ColorectalCancer #clinicaltrials

MMCORC @AllinaHealth Research Day 2026 - sharing a day of innovation and celebration! Together we provide over 100 clinical trial options to the community and have a research team ready to help.

Major HER2+ breast cancer trial identifies factors associated with pathologic complete response to less intensive chemotherapy ecog-acrin.org/press-release…